Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Too much androgen can cause hair loss; finasteride may help.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.